Details for New Drug Application (NDA): 202900
✉ Email this page to a colleague
The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 202900
Tradename: | BUMETANIDE |
Applicant: | Zydus Pharms |
Ingredient: | bumetanide |
Patents: | 0 |
Pharmacology for NDA: 202900
Physiological Effect | Increased Diuresis at Loop of Henle |
Medical Subject Heading (MeSH) Categories for 202900
Suppliers and Packaging for NDA: 202900
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUMETANIDE | bumetanide | TABLET;ORAL | 202900 | ANDA | A-S Medication Solutions | 50090-6137 | 50090-6137-0 | 90 TABLET in 1 BOTTLE (50090-6137-0) |
BUMETANIDE | bumetanide | TABLET;ORAL | 202900 | ANDA | A-S Medication Solutions | 50090-6138 | 50090-6138-2 | 90 TABLET in 1 BOTTLE (50090-6138-2) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Apr 30, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
Approval Date: | Apr 30, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
Approval Date: | Apr 30, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription